Viewing Study NCT04460027


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-25 @ 7:03 PM
Study NCT ID: NCT04460027
Status: COMPLETED
Last Update Posted: 2022-12-21
First Post: 2020-07-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: W-SUDs for COVID-19
Sponsor: Woebot Health
Organization:

Study Overview

Official Title: Woebot for Substance Use Disorders During COVID-19
Status: COMPLETED
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic.

This study that will test the comparative efficacy of the mobile-app based substance use disorder program to reduce substance use relative to a wait list control condition, and explore between group differences on quality of life indices as well as retention and engagement during COVID-19.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
4R44DA048712-02 NIH None https://reporter.nih.gov/quic… View